维力医疗收盘下跌1.07%，滚动市盈率18.47倍，总市值43.29亿元

Core Viewpoint - The company, Weili Medical, is currently facing a decline in stock price and has a lower price-to-earnings (PE) ratio compared to the industry average, indicating potential undervaluation in the medical device sector [1][2]. Company Summary - Weili Medical's stock closed at 14.78 yuan, down 1.07%, with a rolling PE ratio of 18.47 times and a total market capitalization of 4.329 billion yuan [1]. - The company operates in the medical device sector, focusing on the research, production, and sales of medical catheters in areas such as anesthesia, urology, respiration, and hemodialysis [1]. - The latest financial report for the first half of 2025 shows the company achieved a revenue of 745 million yuan, a year-on-year increase of 10.19%, and a net profit of 121 million yuan, up 14.17%, with a gross profit margin of 45.04% [1]. Industry Summary - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, positioning Weili Medical at the 41st rank within the industry [1][2]. - The industry shows a wide range of PE ratios, with the highest being 20.62 times for Antu Biology and the lowest at 11.18 times for Jiuan Medical [2].